Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)—results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care
Titel:
Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)—results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care
Auteur:
Asmis, T.R. Powell, E. Karapetis, C.S. Jonker, D.J. Tu, D. Jeffery, M. Pavlakis, N. Gibbs, P. Zhu, L. Dueck, D.-A. Whittom, R. Langer, C. O'Callaghan, C.J.